KaloBios Pharma (NASDAQ: KBIO) announced that an investor group led by Martin Shkreli, the Founder and Chief Executive Officer of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News Hot Corp. News Hot Mgmt Changes Management Changes Management Comments Momentum Movers Short Sales Trader Talk

KaloBios Pharma (KBIO) Receives NASDAQ Delisting NoticeNovember 23, 2015 5:46 PM KaloBios Pharma (KBIO) Continues Run-Up on Epic Short SqueezeNovember 23, 2015 8:50 AM Macrocure (MCUR) Ramps HigherNovember 20, 2015 10:47 AM Newly-Named KaloBios Pharma (KBIO) CEO Shkreli Briefly Comments on Twitter About AppointmentNovember 20, 2015 6:38 AM KaloBios Pharmaceuticals, Inc. Appoints Martin Shkreli CEO and Announces New FinancingNovember 19, 2015 11:33 PM Needham & Company Drops Coverage of KaloBios Pharma (KBIO) November 19, 2015 4:42 PM Shock of Epic Short Squeeze in KaloBios Pharma (KBIO) Reverberates Across Wall StreetNovember 19, 2015 1:36 PM